Clearside Biomedical Announces Positive Safety Results from Coho
CLSD: Clearside Biomedical, Inc.
2021-06-15 07:05:00
Clearside Biomedical Announces Positive Safety Results from Cohort 1 of OASIS Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD
2021-06-15 07:05:00
Clearside Biomedical Announces Positive Safety Results from Cohort 1 of OASIS Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD